Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q2 2019 Results Conference Call August 15, 2019 4:30 PM ET Company Participants Neda Safarzadeh - Head, IR Joseph Payne - President and CEO Andy Sassine - CFO Dr. Pad Chivukula - Chief Scientific Officer and COO Conference Call Participants Ed Arce - H.C. Wainwright Kumar Raja - Brookline Capital Wangzhi Li - Ladenburg Thalmann Operator Greetings and welcome to the Arcturus Therapeutics Holdings Second Quarter 2019 Earnings Results Conference Call. At this t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Common Stock, par value $0.001 per share ARCT The NASDAQ Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38942 | --- | --- | |----------------------------------- ...